Additionally, CN loss at the EZH2 locus was more common in patients with high-grade MDS than in those with low-grade MDS or normal controls (p = 0.003; p < 0.001) (Figure 2D). The gene discussed is EZH2; the disease is myelodysplastic syndrome.